Table 2.
PRISMA 2020 for abstract checklist [31].
| Section and topic | Item # | Checklist item | Location where Item is reported |
|---|---|---|---|
| Title | 1 | Identify the report as a systematic review | Abstract, line 5. |
| Background | |||
| Objectives | 2 | Provide an explicit statement of the main objective (s) or question (s) the review addresses | Abstract, line 5 |
| Methods | |||
| Eligibility criteria | 3 | Specify the inclusion and exclusion criteria for the review | Not stated in abstract |
| Information sources | 4 | Specify the information sources (e.g., databases and registers) used to identify studies and the date when each was last searched | Abstract, line 6 and 7 |
| Risk of bias | 5 | Specify the methods used to assess risk of bias in the included studies | Abstract, line 7 |
| Synthesis of results | 6 | Specify the methods used to present and synthesize results | Abstract, line 6–8 |
| Results | |||
| Included studies | 7 | Give the total number of included studies and participants and summarize relevant characteristics of studies | Abstract, line 8 |
| Synthesis of results | 8 | Present results for main outcomes, preferably indicating the number of included studies and participants for each. If meta-analysis was done, reports the summary estimate and confidence/credible interval. If comparing groups, indicate the direction of the effects (i.e., which group is favored) | Abstract, line 8–12 |
| Discussion | |||
| Limitation of evidence | 9 | Provide a brief summary of the limitations of the evidence included in the review (e.g., study risk of bias, inconsistency, and imprecision). | Not stated in abstracts |
| Interpretation | 10 | Provide a general interpretation of the results and important implications | Abstract, line 13 and 14 |
| Other | |||
| Funding | 11 | Specify the primary source of funding for the review | Not stated in abstracts |
| Registration | 12 | Provide the register name and registration number | Not stated in abstracts |